Hikma Pharmaceuticals (HIK) News Today GBX 1,851 +14.00 (+0.76%) As of 12:45 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityBuy This Stock HIK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period LONDON MARKET CLOSE: Drug stocks help send FTSE 100 to new record highOctober 1, 2025 | lse.co.ukFTSE 100 hits record as pharma poised to play catch up in Q4October 1, 2025 | fxstreet.comPharma Stocks Drive FTSE 100 Higher Amid Pfizer-US DealOctober 1, 2025 | uk.finance.yahoo.comFTSE 100 hits another high despite concerns over US government shutdownOctober 1, 2025 | msn.comEuropean Pharma Stocks Jump After Trump Unveils Website for DrugsOctober 1, 2025 | msn.comPharma Stocks in Europe Jump After White House Unveils Drug-Buying SiteOctober 1, 2025 | msn.comShares in pharmaceutical firms drop as Trump reveals fresh round of trade tariffsSeptember 26, 2025 | msn.comTrump trade war expands to cover drugs, trucks and furnitureSeptember 26, 2025 | msn.comHikma Pharmaceuticals (LON:HIK) Reaches New 1-Year Low - What's Next?September 25, 2025 | marketbeat.comAG urges Michigan counties, cities to sign up for settlement from opioid makersSeptember 24, 2025 | msn.comThese undervalued FTSE 100 shares could rise more than 50% over the next year, according to brokersSeptember 24, 2025 | msn.comAfter crashing 50%+, is this a bargain-basement growth stock?September 20, 2025 | msn.comHikma Pharmaceuticals PLC (LON:HIK) is favoured by institutional owners who hold 59% of the companySeptember 19, 2025 | finance.yahoo.comMazen Darwazah Buys 14,000 Shares of Hikma Pharmaceuticals (LON:HIK) StockSeptember 18, 2025 | marketbeat.comHikma Pharmaceuticals (LON:HIK) Insider Acquires £224,420 in StockSeptember 18, 2025 | insidertrades.comMurrieta Expected To Join 2 More National Opioid SettlementsSeptember 17, 2025 | msn.comHikma Pharmaceuticals (LON:HIK) Sets New 52-Week Low - Here's WhySeptember 16, 2025 | marketbeat.comHikma Pharmaceuticals (LON:HIK) Reaches New 12-Month Low - What's Next?September 10, 2025 | marketbeat.comWe bought this stock cheap and it’s getting cheaperAugust 26, 2025 | finance.yahoo.comLaura Balan Balan Acquires 3,500 Shares of Hikma Pharmaceuticals (LON:HIK) StockAugust 24, 2025 | marketbeat.comHikma Pharmaceuticals (LON:HIK) Insider Laura Balan Balan Purchases 3,500 SharesAugust 23, 2025 | insidertrades.comGlobal Thyroid Gland Disorder Treatment Market to Increase at a Steady Growth Rate of ~3% by 2032 | DelveInsightAugust 22, 2025 | finance.yahoo.comDeutsche Bank Aktiengesellschaft Issues Pessimistic Forecast for Hikma Pharmaceuticals (LON:HIK) Stock PriceAugust 15, 2025 | marketbeat.comHikma Pharmaceuticals’ Earnings Call: Mixed Financial PerformanceAugust 12, 2025 | msn.comHikma Pharmaceuticals PLC (LON:HIK) Insider Mazen Darwazah Acquires 200,000 SharesAugust 9, 2025 | marketbeat.comHikma Pharmaceuticals (LON:HIK) Stock Price Down 7.1% on Analyst DowngradeAugust 9, 2025 | marketbeat.comHikma Pharmaceuticals (LON:HIK) Given New GBX 2,500 Price Target at JPMorgan Chase & Co.August 9, 2025 | marketbeat.comFTSE 100 slips after BoE rate decision, mixed earnings weigh on sentimentAugust 9, 2025 | msn.comHikma Pharmaceuticals PLC (LON:HIK) Insider Mazen Darwazah Purchases 200,000 SharesAugust 9, 2025 | insidertrades.comU.K. stocks decline for first time in three daysAugust 8, 2025 | marketwatch.comJordan: Hikma Pharmaceuticals records 6% revenue growth in H1 2025August 8, 2025 | msn.comHikma Pharmaceuticals PLC (HKMPF) Q2 2025 Q&A Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comHikma Pharmaceuticals (LON:HIK) Reaches New 52-Week Low - Time to Sell?August 8, 2025 | marketbeat.comHikma Pharmaceuticals (LON:HIK) Earns "Buy" Rating from Jefferies Financial GroupAugust 8, 2025 | marketbeat.comFTSE 100 slips ahead of BoE rate decision, mixed earnings weigh on sentimentAugust 7, 2025 | msn.comFTSE 100 Live: Stocks drop due to ex-div flurry, WPP and Hikma dropAugust 7, 2025 | uk.investing.comAnother $122M from opioid settlements now available to WashingtonJuly 29, 2025 | yahoo.comHikma Pharmaceuticals Donates $1.1 Million in Medical Aid to SyriaJuly 24, 2025 | msn.comHikma Pharmaceuticals (LON:HIK) shareholders have earned a 8.3% CAGR over the last three yearsJuly 23, 2025 | finance.yahoo.comHikma Pharmaceuticals PLC (HIK) Stock Price Today - WSJJuly 15, 2025 | wsj.comHikma Pharmaceuticals slips Friday, underperforms marketJuly 11, 2025 | marketwatch.comNew Hampshire to receive $4.5 million as part of nationwide opioid settlementsJuly 11, 2025 | msn.comDrug maker Hikma announces $1 billion expansion, including its West Side Columbus plantJuly 2, 2025 | msn.comHikma Pharmaceuticals plans USD1 billion investment to support US unitJune 30, 2025 | lse.co.ukCentral Ohio's second-largest manufacturer plans $1B U.S. expansionJune 30, 2025 | bizjournals.comHikma Pharmaceuticals to invest $1B by 2030 to expand US manufacturing, R&DJune 30, 2025 | msn.comHikma Pharmaceuticals (LON:HIK) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?June 19, 2025 | marketbeat.comHikma Pharmaceuticals rallies Thursday, outperforms marketJune 12, 2025 | marketwatch.comHikma Pharmaceuticals (LON:HIK) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?June 11, 2025 | marketbeat.comDIRECTOR DEALINGS: Hikma exec and AB Dynamics advisor sell sharesJune 10, 2025 | lse.co.uk Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HIK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HIK Media Mentions By Week HIK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIK News Sentiment▼0.640.77▲Average Medical News Sentiment HIK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIK Articles This Week▼02▲HIK Articles Average Week Get the Latest News and Ratings for HIK and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies HUTCHMED News Indivior News Allergy Therapeutics News Alliance Pharma News Beximco Pharmaceuticals News Animalcare Group News Shield Therapeutics News Venture Life Group News ECO Animal Health Group News Celadon Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HIK) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
